Valeant’s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers

J. Michael Pearson has become a billionaire from his tough tactics as the head of the fast-growing Valeant Pharmaceuticals International. And consumers like Bruce Mannes, a 68-year-old retired carpenter from Grandville, Mich., are facing the consequences. Mr. Mannes has been taking the same drug, Cuprimine, for 55 years to treat Wilson disease, an inherited disorder […]

Experiment In Coordinated Care For Medicare Failed To Show Savings

A $57 million experiment to provide better, more efficient care at federally funded health centers struggled to meet its goals and is unlikely to save money, says a government report on the project. The test to coordinate treatment for high-risk Medicare patients in hundreds of communities was one of many demonstrations run by the Department […]

Medicare Provides Few Respite Coverage Options For Caregivers

There’s never a shortage of questions about Medicare, the federal health insurance program for people who are 65 or older and some who are disabled. Here are answers to two about respite care and the so-called doughnut hole that limits payments for drugs in Medicare Part D. My 85-year-old husband has been diagnosed with anxiety […]

GAO: More Oversight Needed Over Medicare Advantage

The federal government needs to increase its oversight over private Medicare health plans to make sure seniors have adequate access to doctors and hospitals, according to a report released this week by congressional auditors. The General Accountability Office study found the Centers for Medicare & Medicaid Services, which administers Medicare Advantage plans, primarily relies on […]